Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Gastroenterología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 2
ClinicalTrials.gov
SR121463B in Cirrhotic Ascites Treatment With Hyponatraemia: A Placebo-Controlled, Dose-Comparison Study
INTERVENTIONAL
Inicio: 1 de abr de 2004
ID: NCT00501722
Activo, no recluta
Fase 2
ClinicalTrials.gov
17 β-Hydroxysteroid Dehydrogenase Type 13 Minimization for the Treatment of NASH (HORIZON): A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of GSK4532990 in Adults With Nonalcoholic Steatohepatitis
INTERVENTIONAL
Inicio: 2 de ene de 2023
ID: NCT05583344
Terminado
Fase 2
ClinicalTrials.gov
A 24-week, Multicenter, Randomized, Double-blind, Parallel-arm, Placebo-controlled Extension Study to Assess the Safety of CSJ117, When Added to Existing Standard of Care Asthma Therapy in Patients ≥18 Years of Age
INTERVENTIONAL
Inicio: 8 de sept de 2021
ID: NCT04946318
Retirado
Fase 2
ClinicalTrials.gov
A Randomized, Active-Controlled, Open-Label, Phase 2 Clinical Trial of BMS-986213, in Combination With Various Standard-of-Care Therapeutic Regimens, in Participants With Recurrent, Locally Advanced, or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction (GEJ) Adenocarcinoma
INTERVENTIONAL
Inicio: 31 de oct de 2019
ID: NCT03704077
Activo, no recluta
ClinicalTrials.gov
Pilot Study to Evaluate the Safety and Effectiveness of the CereVasc® eShunt® System in the Treatment of Normal Pressure Hydrocephalus
INTERVENTIONAL
Inicio: 10 de mar de 2022
ID: NCT05250505
Desconocido
ClinicalTrials.gov
Impact of Coronavirus Disease 2019 (COVID-19) Epidemic in Patients Requiring Liver Transplantation
OBSERVATIONAL
Inicio: 15 de dic de 2020
ID: NCT04695756
Completado
ClinicalTrials.gov
Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS): Safety, Feasibility and Efficacy at a Single Center
OBSERVATIONAL
Inicio: 1 de jun de 2011
ID: NCT02164292
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
INTERVENTIONAL
Inicio: 19 de oct de 2018
ID: NCT03524092
Completado
Fase 3
ClinicalTrials.gov
A Phase III Study for ErbB2 Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Junction Adenocarcinoma Treated With Capecitabine Plus Oxaliplatin With or Without Lapatinib
INTERVENTIONAL
Inicio: 4 de jun de 2008
ID: NCT00680901
Completado
Fase 2
ClinicalTrials.gov
A Phase 2a, Randomized, Active-Comparator-Controlled, Open-Label Study to Evaluate the Efficacy and Safety of Efinopegdutide (MK-6024) in Individuals With Nonalcoholic Fatty Liver Disease
INTERVENTIONAL
Inicio: 4 de ago de 2021
ID: NCT04944992
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Double-blind, Randomized, Placebo-Controlled Study and Open-label Long Term Extension to Evaluate the Efficacy and Safety of Elafibranor 80 mg in Patients With Primary Biliary Cholangitis With Inadequate Response or Intolerance to Ursodeoxycholic Acid
INTERVENTIONAL
Inicio: 24 de sept de 2020
ID: NCT04526665
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Capecitabine and Cisplatin With or Without Ramucirumab as First-line Therapy in Patients With Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (RAINFALL)
INTERVENTIONAL
Inicio: 20 de ene de 2015
ID: NCT02314117
Completado
Fase 3
ClinicalTrials.gov
Phase 3 Randomized, Double-Blind, Placebo Controlled Induction Study of Sargramostim (Leukine®) in Patients With Active Crohn's Disease
INTERVENTIONAL
Inicio: 1 de sept de 2004
ID: NCT00206674
Completado
Fase 3
ClinicalTrials.gov
A Randomised, Double-blind, Double-dummy, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of 48 Weeks of Once Daily Treatment of Orally Inhaled BI 1744 CL (5 µg [2 Actuations of 2.5 ug] and 10 ug [2 Actuations of 5 ug]) Delivered by the Respimat® Inhaler, and 48 Weeks of Twice Daily Foradil® (12 µg) Delivered by the Aerolizer® Inhaler, in Patients With Chronic Obstructive Pulmonary Disease (COPD)
INTERVENTIONAL
Inicio: 1 de feb de 2009
ID: NCT00793624
Activo, no recluta
Fase 3
ClinicalTrials.gov
Phase 3 Multicenter, Randomized, Double-Blind, Study to Assess the Efficacy and Safety of Treatment With Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B Virus (B-Well 2)
INTERVENTIONAL
Inicio: 6 de dic de 2022
ID: NCT05630820
Completado
Fase 3
ClinicalTrials.gov
Study of the Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection
INTERVENTIONAL
Inicio: 1 de abr de 2007
ID: NCT00395018
Completado
Fase 2
ClinicalTrials.gov
A Randomized, Double-blind, Multicenter Study to Assess the Safety, Tolerability, and Efficacy of a Combination Treatment of Tropifexor (LJN452) and Cenicriviroc (CVC) in Adult Patients With Nonalcoholic Steatohepatitis (NASH) and Liver Fibrosis
INTERVENTIONAL
Inicio: 11 de sept de 2018
ID: NCT03517540
Completado
ClinicalTrials.gov
Diet as Adjuvant Therapeutics in the Era of Biologics in Pediatric-onset Crohn's Disease.
INTERVENTIONAL
Inicio: 14 de may de 2021
ID: NCT05034458
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase IIIb, Global, Multicenter, Randomized, Visual Assessor-Masked Study of the Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)
INTERVENTIONAL
Inicio: 14 de jul de 2021
ID: NCT04657289
Completado
ClinicalTrials.gov
Exploratory, Randomized, Double-blind, Placebo-Controlled Study on the Effects of Bifidobacterium Infantis in Active Celiac Disease
INTERVENTIONAL
Inicio: 1 de dic de 2010
ID: NCT01257620
Anterior
1
...
14
15
16
...
434
Siguiente
Filtros